leisure time -WSS

leisure time

author：entertainment 2025-09-03 09:22:04 - browse：7934

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Just how do doctors, lawmakers, and the public define abortion?

hotspot

WSS

The Readout: Amylyx, Alumis, and Lundbeck drug updates

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

It's time to retire 'poor historian' from clinicians' vocabularies

Case highlights the risks of experimental stem cell therapy

focus

leisure time

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Change Healthcare payments predicted restored March 15

Virginia high school admissions case could be legal follow

Addiction experts warn against a second 'war on drugs'

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Medical leaders decry Supreme Court decision on affirmative action

IVF, abortion rights issues kick off Biden’s State of the Union

In Memoriam: Notable people who died in 2023

HIV vaccine remains elusive. Immunologists keep trying new ideas

leisure time

What it’s like to watch children die of measles

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

When prostate cancer spreads, where it goes matters

Arc Institute generative AI designs new CRISPR systems

Readers respond to H5N1 and livestock movements, and more

hotspot

hotspot

knowledge

leisure time